Several reports indicated that ASS1 can be regulated by oncogene/tumor suppressors (such as MYC, p53) and epigenetic modifications 46, 47, and ASS1 expression is downregulated in HCC. This evidence concerns the gene TP53 and hepatocellular carcinoma.